Patents by Inventor Christopher D. Breder

Christopher D. Breder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treatment of CNS disorders
    Patent number: 11911368
    Abstract: The invention comprises a method of treatment of CNS disorders by a pharmaceutical agent exhibiting combined noradrenergic, serotonergic or dopaminergic reuptake transporter inhibitory and ?-opioid agonistic activity.
    Type: Grant
    Filed: November 8, 2019
    Date of Patent: February 27, 2024
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. Breder
  • METHOD OF TREATMENT OF CNS DISORDERS
    Publication number: 20230355589
    Abstract: The invention comprises a method of treatment of CNS disorders by a pharmaceutical agent exhibiting combined noradrenergic, serotonergic or dopaminergic reuptake transporter inhibitory and ?-opioid agonistic activity
    Type: Application
    Filed: July 17, 2023
    Publication date: November 9, 2023
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. Breder
  • Method of treatment of aggression
    Patent number: 11638708
    Abstract: The invention comprises a method of treatment of aggression and similar behavioral syndromes, such as impulsivity and irritability, by a pharmaceutical agent exhibiting combined D2 and D5 antagonistic activity.
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: May 2, 2023
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. Breder
  • METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
    Publication number: 20230102784
    Abstract: The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.
    Type: Application
    Filed: August 26, 2022
    Publication date: March 30, 2023
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. BREDER
  • Method of treatment of attention deficit/hyperactivity disorder (ADHD)
    Patent number: 11458143
    Abstract: The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.
    Type: Grant
    Filed: April 12, 2022
    Date of Patent: October 4, 2022
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. Breder
  • METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
    Publication number: 20220233548
    Abstract: The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.
    Type: Application
    Filed: April 12, 2022
    Publication date: July 28, 2022
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. BREDER
  • Method of treatment of attention deficit/hyperactivity disorder (ADHD)
    Patent number: 11324753
    Abstract: The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: May 10, 2022
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. Breder
  • METHOD OF TREATMENT OF CNS DISORDERS
    Publication number: 20200069653
    Abstract: The invention comprises a method of treatment of CNS disorders by a pharmaceutical agent exhibiting combined noradrenergic, serotonergic or dopaminergic reuptake transporter inhibitory and ?-opioid agonistic activity.
    Type: Application
    Filed: November 8, 2019
    Publication date: March 5, 2020
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. Breder
  • METHOD OF TREATMENT OF AGGRESSION
    Publication number: 20200022986
    Abstract: The invention comprises a method of treatment of aggression and similar behavioral syndromes, such as impulsivity and irritability, by a pharmaceutical agent exhibiting combined D2 and D5 antagonistic activity.
    Type: Application
    Filed: January 4, 2019
    Publication date: January 23, 2020
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. BREDER
  • Method of treatment of aggression
    Patent number: 10201547
    Abstract: The invention comprises a method of treatment of aggression and similar behavioral syndromes, such as impulsivity and irritability, by a pharmaceutical agent exhibiting combined D2 and D5 antagonistic activity.
    Type: Grant
    Filed: July 26, 2018
    Date of Patent: February 12, 2019
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. Breder
  • METHOD OF TREATMENT OF AGGRESSION
    Publication number: 20180325912
    Abstract: The invention comprises a method of treatment of aggression and similar behavioral syndromes, such as impulsivity and irritability, by a pharmaceutical agent exhibiting combined D2 and D5 antagonistic activity.
    Type: Application
    Filed: July 26, 2018
    Publication date: November 15, 2018
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. BREDER
  • Method of treatment of aggression
    Patent number: 10058556
    Abstract: The invention comprises a method of treatment of aggression and similar behavioral syndromes, such as impulsivity and irritability, by a pharmaceutical agent exhibiting combined D2 and D5 antagonistic activity.
    Type: Grant
    Filed: October 12, 2017
    Date of Patent: August 28, 2018
    Assignee: SUPERNUS PHARMACEUTICALS, INC.
    Inventor: Christopher D. Breder
  • METHOD OF TREATMENT OF AGGRESSION
    Publication number: 20180055853
    Abstract: The invention comprises a method of treatment of aggression and similar behavioral syndromes, such as impulsivity and irritability, by a pharmaceutical agent exhibiting combined D2 and D5 antagonistic activity.
    Type: Application
    Filed: October 12, 2017
    Publication date: March 1, 2018
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. BREDER
  • Method of treatment of aggression
    Patent number: 9801887
    Abstract: The invention comprises a method of treatment of aggression and similar behavioral syndromes, such as impulsivity and irritability, by a pharmaceutical agent exhibiting combined D2 and D5 antagonistic activity.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: October 31, 2017
    Assignee: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. Breder
  • METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
    Publication number: 20170266195
    Abstract: The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.
    Type: Application
    Filed: June 6, 2017
    Publication date: September 21, 2017
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. BREDER
  • METHOD OF TREATMENT OF CNS DISORDERS
    Publication number: 20160136135
    Abstract: The invention comprises a method of treatment of CNS disorders by a pharmaceutical agent exhibiting combined noradrenergic, serotonergic or dopaminergic reuptake transporter inhibitory and ?-opioid agonistic activity.
    Type: Application
    Filed: July 10, 2015
    Publication date: May 19, 2016
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. Breder
  • METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
    Publication number: 20150290202
    Abstract: The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.
    Type: Application
    Filed: February 27, 2015
    Publication date: October 15, 2015
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. BREDER
  • METHOD OF TREATMENT OF AGGRESSION
    Publication number: 20140187552
    Abstract: The invention comprises a method of treatment of aggression and similar behavioral syndromes, such as impulsivity and irritability, by a pharmaceutical agent exhibiting combined D2 and D5 antagonistic activity.
    Type: Application
    Filed: July 26, 2013
    Publication date: July 3, 2014
    Applicant: Supernus Pharmaceuticals, Inc.
    Inventor: Christopher D. Breder
  • METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
    Publication number: 20130289035
    Abstract: The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.
    Type: Application
    Filed: June 28, 2013
    Publication date: October 31, 2013
    Inventor: Christopher D. Breder
  • METHOD OF TREATMENT OF CNS DISORDERS
    Publication number: 20120302615
    Abstract: The invention comprises a method of treatment of CNS disorders by a pharmaceutical agent exhibiting combined noradrenergic, serotonergic or dopaminergic reuptake transporter inhibitory and ?-opioid agonistic activity.
    Type: Application
    Filed: December 2, 2010
    Publication date: November 29, 2012
    Inventor: Christopher D. Breder